{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T04:05:22Z","timestamp":1748923522076,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute (NCI) in Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Axillary dissection has been shown to be equivalent to axillary radiotherapy in the AMAROS trial; however, extracapsular invasion of sentinel lymph nodes was not considered among the evaluated variables. The clinical significance of extracapsular extension (ECE) in one or two positive sentinel lymph nodes remains under investigation. This study aims to evaluate the impact of targeted axillary radiation therapy while omitting completion axillary lymph node dissection (ALND) in the presence of extracapsular extension.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective study was conducted between 2016 and 2023 involving cT1\u20132N0 breast cancer patients who did not receive neoadjuvant chemotherapy and underwent either breast-conserving surgery or mastectomy, with extracapsular extension present in one or two positive sentinel lymph nodes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our study included 213 patients treated between 2016 and 2023, with a median follow-up of 48.07 months (range: 9.07\u2013103.10 months). ECE was \u2264\u20092\u00a0mm in 201 patients (94.4%) and &gt;\u20092\u00a0mm in 12 patients (5.6%). A total of 112 patients (52.6%) underwent completion ALND. Systemic recurrence occurred in 24 patients (11.3%), while local recurrence occurred in one patient (0.5%). The 5-year disease-free survival (DFS) rates were 86% in the completion axillary clearance (AC) group and 89% in the non-AC group. The estimated DFS rates for the entire study at 1, 3, and 5 years were 97%, 89%, and 86%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Within this single-institution study of early breast cancer patients with predominantly luminal A subtype and mostly limited ECE (\u2264\u20092\u00a0mm) treated with targeted axillary radiation, omission of ALND did not result in inferior DFS compared to completion ALND. However, these findings are preliminary, hypothesis-generating, and limited by the retrospective design, short follow-up, and specific patient population studied. Prospective studies are needed to confirm these observations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Retrospectively registered after the approval of Baheya Ethical Committee, IRB no. 202,304,030,017.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12893-025-02974-x","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:13:24Z","timestamp":1748837604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of targeted axillary radiation therapy with omission of axillary dissection in early breast cancer patients with one or two positive sentinel lymph nodes and extracapsular extension"],"prefix":"10.1186","volume":"25","author":[{"given":"Ahmed","family":"Orabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"G. Ellaithy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Guimei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"H. Ibraheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Mohamed M. Fadlalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Fathy Abdelfattah Abdelrahman Elith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine","family":"Hany Abdel Moamen Elzohery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"S. Abdelmomen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Nasser Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2974_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12885-024-11853-2","volume":"24","author":"H Shao","year":"2024","unstructured":"Shao H, Sun Y, Na Z, et al. Diagnostic value of applying preoperative breast ultrasound and clinicopathologic features to predict axillary lymph node burden in early invasive breast cancer: a study of 1247 patients. BMC Cancer. 2024;24:112. https:\/\/doi.org\/10.1186\/s12885-024-11853-2.","journal-title":"BMC Cancer"},{"issue":"8","key":"2974_CR2","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1245\/s10434-022-11829-1","volume":"29","author":"JC Radosa","year":"2022","unstructured":"Radosa JC, Solomayer EF, Deeken M, Minko P, Zimmermann JSM, Kaya AC, Radosa MP, Stotz L, Huwer S, M\u00fcller C, Karsten MM, Wagenpfeil G, Radosa CG. Preoperative sonographic prediction of limited axillary disease in patients with primary breast Cancer meeting the Z0011 criteria: an alternative to Sentinel node biopsy?? Ann Surg Oncol. 2022;29(8):4764\u201372. https:\/\/doi.org\/10.1245\/s10434-022-11829-1. Epub 2022 Apr 29. PMID: 35486266; PMCID: PMC9246792.","journal-title":"Ann Surg Oncol"},{"issue":"18suppl","key":"2974_CR3","doi-asserted-by":"publisher","first-page":"LBA1001","DOI":"10.1200\/jco.2013.31.18_suppl.lba1001","volume":"31","author":"E Rutgers","year":"2013","unstructured":"Rutgers E, Donker M, Straver M, et al. Radiotherapy or surgery of the axilla after a positive Sentinel node in breast cancer patients: final analysis of the EORTC AMAROS trial (10981\/22023). J Clin Oncol. 2013;31(18suppl):LBA1001\u20131001. https:\/\/doi.org\/10.1200\/jco.2013.31.18_suppl.lba1001.","journal-title":"J Clin Oncol"},{"key":"2974_CR4","unstructured":"National Comprehensive Cancer Network\u00ae. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 3.2025. 2025. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1419"},{"key":"2974_CR5","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1245\/s10434-015-4717-7","volume":"22","author":"RS Jackson","year":"2015","unstructured":"Jackson RS, Mylander C, Rosman M, Andrade R, Sawyer K, Sanders P, Tafra L. Normal axillary ultrasound excludes heavy nodal disease burden in patients with breast cancer. Ann Surg Oncol. 2015;22:3289\u201395.","journal-title":"Ann Surg Oncol"},{"key":"2974_CR6","first-page":"1","volume":"12","author":"D Artmoniene","year":"2019","unstructured":"Artmoniene D. Breast cancer: the accuracy of the Paus in detecting pN2 and factors that lead to the true- and false-negative results. Biomed J Sci Tech Res. 2019;12:1\u20139.","journal-title":"Biomed J Sci Tech Res"},{"key":"2974_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jss.2015.03.057","volume":"198","author":"IY Nwaogu","year":"2015","unstructured":"Nwaogu IY, Yan Y, Appleton CM, Cyr AE, Margenthaler JA. Predictors of false negative axillary ultrasound in breast cancer. J Surg Res. 2015;198:351\u20134.","journal-title":"J Surg Res"},{"key":"2974_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/medicina56030127","volume":"56","author":"D Rukanskien\u0117","year":"2020","unstructured":"Rukanskien\u0117 D, Veikutis V, Jonaitien\u0117 E, Basevi\u010di\u016bt\u0117 M, Kunigi\u0161kis D, Pauk\u0161taitien\u0117 R, \u010cepulien\u0117 D, Po\u0161kien\u0117 L, Bogu\u0161evi\u010dius A. Preoperative axillary ultrasound versus Sentinel lymph node biopsy in patients with early breast Cancer. Medicina. 2020;56:127.","journal-title":"Medicina"},{"key":"2974_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5603\/NJO.a2020.0037","volume":"70","author":"P K\u0119dzierawski","year":"2020","unstructured":"K\u0119dzierawski P. Breast cancer\u2013 extracapsular extension in the Sentinel lymph node. NOWOTWORY J Oncol. 2020;70:203\u20135.","journal-title":"NOWOTWORY J Oncol"},{"key":"2974_CR10","doi-asserted-by":"publisher","first-page":"100216","DOI":"10.1016\/j.clinsp.2023.100216","volume":"78","author":"GB Freitas","year":"2023","unstructured":"Freitas GB, Mota BS, Maesaka JY, Pinheiro CC, de Lima LGCA, Soares JM Jr, Baracat EC, Filassi JR. Measurement of extracapsular extension in Sentinel lymph node as a possible predictor of residual axillary disease in breast cancer. Clin (Sao Paulo). 2023;78:100216. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100216. PMID: 37201303; PMCID: PMC10205584.","journal-title":"Clin (Sao Paulo)"},{"key":"2974_CR11","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.suronc.2021.101594","volume":"38","author":"M Layse de Menezes Dantas","year":"2021","unstructured":"Layse de Menezes Dantas M, Hugo da Silva Santos Y, Alc\u00e2ntara da Silva PH, Medeiros de Azevedo F, Petta TB, Sampaio Marinho Navarro DT. Prevalence of extracapsular extension in metastatic Sentinel lymph nodes in breast cancer. Surg Oncol. 2021;38:101594. Epub 2021 Apr 25. PMID: 33930842.","journal-title":"Surg Oncol"},{"key":"2974_CR12","doi-asserted-by":"publisher","first-page":"9534","DOI":"10.1038\/s41598-021-88716-4","volume":"11","author":"X Ma","year":"2021","unstructured":"Ma X, Yang X, Yang W, et al. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer. Sci Rep. 2021;11:9534. https:\/\/doi.org\/10.1038\/s41598-021-88716-4.","journal-title":"Sci Rep"},{"issue":"4","key":"2974_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/tbj.12983","volume":"24","author":"L Schwentner","year":"2018","unstructured":"Schwentner L, Dayan D, W\u00f6ckel A, et al. Is extracapsular nodal extension in Sentinel nodes a predictor for nonsentinel metastasis and is there an impact on survival parameters?-A retrospective single center cohort study with 324 patients. Breast J. 2018;24(4):480\u20136. https:\/\/doi.org\/10.1111\/tbj.12983. indexed in Pubmed: 29265572.","journal-title":"Breast J"},{"issue":"3","key":"2974_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10549-018-05074-y","volume":"174","author":"MLG Vane","year":"2019","unstructured":"Vane MLG, Willemsen MA, van Roozendaal LM, et al. Extracapsular extension in the positive Sentinel lymph node: a marker of poor prognosis in cT1-2N0 breast cancer patients? Breast Cancer Res Treat. 2019;174(3):711\u20138. https:\/\/doi.org\/10.1007\/s10549-018-05074-y. indexed in Pubmed: 30610488.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"2974_CR15","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.5858\/arpa.2014-0375","volume":"139","author":"E Drinka","year":"2015","unstructured":"Drinka E, Allen P, McBride A, et al. Metastatic tumor volume and extranodal tumor extension: clinical significance in patients with stage II breast Cancer. Arch Pathol Lab Med. 2015;139(10):1288\u201394. https:\/\/doi.org\/10.5858\/arpa.2014-0375. -OA, indexed in Pubmed: 25768237.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"2974_CR16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/000313481408001004","volume":"80","author":"AH Choi","year":"2014","unstructured":"Choi AH, Surrusco M, Rodriguez S, et al. Extranodal extension on Sentinel lymph node dissection: why should we treat it differently? Am Surg. 2014;80(10):932\u20135. indexed in Pubmed: 25264632.","journal-title":"Am Surg"},{"key":"2974_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10147-012-0439-z","volume":"18","author":"E Dobi","year":"2013","unstructured":"Dobi E, et al. Is extracapsular tumour spread a prognostic factor in patients with early breast cancer? Int J Clin Oncol. 2013;18:607\u201313.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"2974_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/SLA.0000000000002354","volume":"266","author":"M Morrow","year":"2017","unstructured":"Morrow M, Van Zee KJ, Patil S, Petruolo O, Mamtani A, Barrio AV, Capko D, El-Tamer M, Gemignani ML, Heerdt AS, Kirstein L, Pilewskie M, Plitas G, Sacchini VS, Sclafani LM, Ho A, Cody HS. Axillary dissection and nodal irradiation can be avoided for most Node-positive Z0011-eligible breast cancers: A prospective validation study of 793 patients. Ann Surg. 2017;266(3):457\u201362. https:\/\/doi.org\/10.1097\/SLA.0000000000002354. PMID: 28650355; PMCID: PMC5649371.","journal-title":"Ann Surg"},{"issue":"5","key":"2974_CR19","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1245\/s10434-019-08104-1","volume":"27","author":"AV Barrio","year":"2020","unstructured":"Barrio AV, Downs-Canner S, Edelweiss M, Van Zee KJ, Cody HS 3rd, Gemignani ML, Pilewskie ML, Plitas G, El-Tamer M, Kirstein L, Capko D, Patil S, Morrow M. Microscopic extracapsular extension in Sentinel lymph nodes does not mandate axillary dissection in Z0011-Eligible patients. Ann Surg Oncol. 2020;27(5):1617\u201324. https:\/\/doi.org\/10.1245\/s10434-019-08104-1. Epub 2019 Dec 9. PMID: 31820212; PMCID: PMC7145724.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"2974_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.adro.2018.03.004","volume":"3","author":"BJ Gebhardt","year":"2018","unstructured":"Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Farrugia DJ, Diego E, Ahrendt GM, Beriwal S. Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial? Adv Radiat Oncol. 2018;3(3):258\u201364. PMID: 30197938; PMCID: PMC6127974.","journal-title":"Adv Radiat Oncol"},{"key":"2974_CR21","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.ejrad.2016.10.030","volume":"85","author":"TJA Van Nijnatten","year":"2016","unstructured":"Van Nijnatten TJA, Ploumen EH, Schipper RJ, Goorts B, Andriessen EH, Vanwetswinkel S, Schavemaker M, Nelemans P, de Vries B, Beets-Tan RGH, et al. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients. Eur J Radiol. 2016;85:2288\u201394.","journal-title":"Eur J Radiol"},{"key":"2974_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2214\/AJR.12.9036","volume":"200","author":"H Abe","year":"2013","unstructured":"Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. Am J Roentgenol. 2013;200:696\u2013702.","journal-title":"Am J Roentgenol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-02974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-02974-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-02974-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T16:02:14Z","timestamp":1748880134000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-025-02974-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2974"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-02974-x","relation":{},"ISSN":["1471-2482"],"issn-type":[{"type":"electronic","value":"1471-2482"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained a waiver of informed consent from the Institutional Review Board (IRB) of the Baheya Research Ethical Committee at Baheya Center for Early Detection and Treatment of Breast Cancer (IRB No. 202304030017). This study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}